Business Wire

Amadeus Travel Dreams 2026 : How AI, Mental Wellbeing, and Sustainability Are Redefining Travel Value

15.4.2026 13:00:00 CEST | Business Wire | Press Release

Share

New insights from transformative technology provider, Amadeus, have revealed modern travel is increasingly being used as a mental health reset, not just as a leisure activity. New research project, Travel Dreams 2026: From data to delight, finds many travelers are this year prioritizing having a ‘refreshed brain’ alongside ‘finding a new version of themselves’ and ‘greater confidence and independence’.

Some 41% of the 6,000 travelers surveyed aspire to return from a trip with a calmer nervous system, while a third of them describe an ideal destination as one where they are inspired to digitally detox because the world around them is more interesting.

Francisco Pérez-Lozao Rüter, President, Hospitality, Amadeus, says: “Travel Dreams 2026 has clear implications for the hospitality sector. Mental wellbeing is no longer a spa-only concept. It’s embedded in operational details such as giving travelers back time, quiet, and comfort, as well as emotional safety. Hotels that design experiences to reduce cognitive load, rather than adding stimulation, are better aligned with how travelers now use travel as a form of self-regulation and recovery.”

Personalized attributes can unlock US$1 million per year, per hotel – without adding a single room

The focus on mental health is further reflected in Travel Dreams2026 research, which shows guests are willing to pay a premium for features that reduce friction, add comfort, and give them a sense of control. The top six revenue generating attributes identified were (in order of traveler preference):

  1. Early check-in / late check-out
  2. Room view / floor selection
  3. Personalized welcome amenities
  4. Sleep optimization packages
  5. Enhanced oxygen and air quality in rooms
  6. Local experience kits / curated guides

Some 74% of travelers say they want their trips to be personalized, and the results suggest that if modern retailing opportunities like room attributes are pitched strategically, they can deliver significant returns. A 150-room, mid-scale hotel could generate an additional US$1million in incremental annual revenue by monetizing these popular attributes.

AI critical to reducing friction - but must not replace the human touch

AI implementation is accelerating – with only one hotelier out of 500 questioned not planning to invest in this area in 2026. Per hotel, the average spend being earmarked for AI in 2026 is $320,000, rising to $400,000 in the United States. Hoteliers say this spend will focus on revenue intelligence, forecasting, automation, and chatbots.

Getting generative engine optimization (GEO) and search engine optimization (SEO) right is the top reported demand-generation priority for hoteliers in 2026. With 69% of travelers reportedly relying solely on AI search summaries, visibility within generative search is now essential to reaching target audiences.

Francisco Pérez-Lozao Rüter adds: “With AI adoption becoming virtually universal among hoteliers around the world and generative search reshaping how travelers discover and choose brands, 2026 will be the year the industry turns digital ambition into decisive, competitive action.”

However, Travel Dreams 2026 research makes one thing clear: travelers still value the human touch – they want people to welcome them, help them, and look after them. These results suggest that AI may be best working quietly in the background: adapting rooms to their preferences, minimizing waiting and uncertainty, and helping staff respond faster, so the entire stay feels effortless.

Sustainability shown as key differentiator - and could drive room premiums of nearly 12%

Sustainability has shifted from a ‘nice to have’ to a core expectation, with three quarters of travelers saying sustainability credentials influence their hotel choice. Among travelers who value sustainability, many are also willing to pay a price premium, averaging 11.7% more for a night at a hotel with stronger environmental practices.

All the hoteliers researched in Travel Dreams 2026 said they are actively planning to spend on sustainability initiatives in 2026 with an average spend of around 7% of total business expenditure. Over a third of hoteliers (35%) also stated that sustainability was a key factor in how they differentiate a property.

Francisco Pérez-Lozao Rüter, President, Hospitality, Amadeus, comments, “AI and sustainability are reshaping travel: both must enhance the human experience rather than replace it. AI should work behind the scenes and aim to reduce friction, anticipate needs, and let staff focus on welcoming and caring for guests, while strong environmental credentials build trust, influence choices, and can even justify premium pricing. Together, they define the hotels that travelers increasingly seek.”

Download the full Travel Dreams 2026: From data to delight report here.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260415457641/en/

Contacts

Ellie Box
ebox@fireoth.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press Release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that

Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press Release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that

2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press Release

The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen Chupka, executive vice president, National Association of Broadcasters. “This year’s Show reflects the accelerating pace of innovation and

2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press Release

The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen Chupka, executive vice president, National Association of Broadcasters. “This year’s Show reflects the accelerating pace of innovation and

Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product17.4.2026 23:43:00 CEST | Press Release

The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes. The agency concluded that renewing the IQOS and HEETS MRTP authorizations is appropriate to promote public health and is expected to benefit the health of the population as a whole taking into account both users of tobacco products and persons who do not currently use tobacco products. “As the only company to have successfully secured and maintained MRTP authorizations for heated tobacco products in the U.S., we are confident that our science-based alternatives can help adult smokers transition away from combustible cigarettes,” said Stacey Kenned

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye